NECTAR LIFESCIENCES LTD UNIT II

Company Type: Factory (Manufacturer)

Company Introduction:

Nectar Lifesciences Ltd. (NELCO) is a prominent Indian pharmaceutical company with a significant global footprint. Unit II refers to one of its advanced manufacturing facilities, primarily engaged in the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished dosage forms. The company is dedicated to manufacturing high-quality, cost-effective pharmaceutical products that cater to various therapeutic segments worldwide. Nectar Lifesciences operates with a strong commitment to international quality standards and regulatory compliance, ensuring product efficacy and safety. Its operations are supported by robust research and development capabilities and extensive manufacturing infrastructure, positioning it as a key player in the global pharmaceutical industry.

Products manufactured or sold by NECTAR LIFESCIENCES LTD UNIT II include:

Active Pharmaceutical Ingredients (APIs) across various therapeutic segments, prominently featuring:

Cephalosporins:

Cefixime

Cefpodoxime Proxetil

Cefuroxime Axetil

Ceftriaxone Sodium

Cefotaxime Sodium

Ceftazidime

Cefepime HCl

Cefazolin Sodium

Carbapenems:

Meropenem

Ertapenem

Imipenem

Doripenem

Other APIs:

Azithromycin

Clarithromycin

Linezolid

Moxifloxacin HCl

Levofloxacin HCl

Ofloxacin

Gatifloxacin

Gemifloxacin

Finished Dosage Forms (FDFs):

Various formulations such as tablets, capsules, injections, and oral suspensions, primarily in the anti-infective and antibiotic categories, often leveraging their in-house API production.